EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Guidance on the Management of Asymptomatic Blood Donors Who Test Positive for Babesia

Evan M Bloch iD, Jeremy W Jacobs iD, Edouard Vannier iD, Gary P Wormser, Jeffrey A Gelfand, Vijay K Sikand, Howard M Heller iD, Sunil K Sood, Laura Kirkman iD, Jennie E Johnson iD, Luis A Marcos iD, Jacob E Lemieux und 8 weitere

Clinical Infectious Diseases · 2025

DOI: 10.1093/cid/ciaf721 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Evan M Bloch und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Babesiosis, Blood Donors, Babesia, Asymptomatic Infections. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NCPDCID CDC HHS, CDC HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Regional blood donor screening for Babesia has been conducted in the United States since 2019, using highly sensitive and specific nucleic acid testing (NAT). Currently, there are no recommendations regarding the management of asymptomatic blood donors who test positive for Babesia.

Methods

A multidisciplinary expert panel was convened to develop guidance for the management of asymptomatic Babesia-infected blood donors. Additionally, a survey was distributed through the Infectious Diseases Society of America (IDSA) Emerging Infections Network (EIN) to evaluate how a geographically diverse group of infectious diseases specialists would approach this problem.

Results

The expert panel recommends that all Babesia NAT-positive blood donors should be referred for clinical evaluation and retesting using peripheral blood smear (PBS) and Babesia PCR. The panel also recommends observation rather than treatment for a reactive molecular test alone. Antimicrobial therapy should be considered for PBS-positive cases. Donors should be instructed to seek medical care if symptoms develop. The EIN survey results are consistent with these recommendations.

Conclusions

Since blood donors comprise healthy, immunocompetent adults, findings of incidental Babesia infections in asymptomatic donors are frequently self-limited. Longitudinal studies show that molecular evidence of infection in blood donors clears in almost all without intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BabesiosisBlood DonorsBabesiaAsymptomatic InfectionsHumansBlood DonationUnited StatesMass Screening

Stichwörter der Autor:innen

Babesia; blood donors; screening; babesiosis; guideline

Autor:innen und Institutionen

  • Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, Tennessee, USA.
  • Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, Massachusetts, USA.
  • Division of Infectious Diseases, New York Medical College, Valhalla, New York, USA.
  • Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts, USA.

ORCID-Profile: Evan M Bloch, Jeremy W Jacobs, Edouard Vannier, Howard M Heller, Laura Kirkman, Jennie E Johnson, Luis A Marcos, Whitney A Perry, Philip M Polgreen, David J Sullivan, Paul G Auwaerter, Peter J Krause

Förderung

  • NHLBI NIH HHS
  • NCPDCID CDC HHS
  • CDC HHS
  • Llura A. Gund Laboratory for Vector borne Disease Research
  • Gordon and Llura Gund Foundation
  • Ken and Sherrilyn Fisher Center for Environmental Infectious Diseases
  • Centers for Disease Control and Prevention

Zitieren

APA

Bloch, E. M., Jacobs, J. W., Vannier, E., Wormser, G. P., Gelfand, J. A., Sikand, V. K., Heller, H. M., Sood, S. K., Kirkman, L., Johnson, J. E., Marcos, L. A., Lemieux, J. E., Smith, R. P., Woolley, A. E., Perry, W. A., Polgreen, P. M., Beekmann, S. E., Sullivan, D. J., Auwaerter, P. G., & Krause, P. J. (2025). Guidance on the Management of Asymptomatic Blood Donors Who Test Positive for Babesia. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf721

Vancouver

Bloch EM, Jacobs JW, Vannier E, Wormser GP, Gelfand JA, Sikand VK, et al. Guidance on the Management of Asymptomatic Blood Donors Who Test Positive for Babesia. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf721

BibTeX
@article{Bloch2025,
  author = {Bloch, Evan M and Jacobs, Jeremy W and Vannier, Edouard and Wormser, Gary P and Gelfand, Jeffrey A and Sikand, Vijay K and Heller, Howard M and Sood, Sunil K and Kirkman, Laura and Johnson, Jennie E and Marcos, Luis A and Lemieux, Jacob E and Smith, Robert P and Woolley, Ann E and Perry, Whitney A and Polgreen, Philip M and Beekmann, Susan E and Sullivan, David J and Auwaerter, Paul G and Krause, Peter J},
  title = {Guidance on the Management of Asymptomatic Blood Donors Who Test Positive for Babesia},
  journal = {Clinical Infectious Diseases},
  year = {2025},
  doi = {10.1093/cid/ciaf721}
}
Kostenlos starten →